Medix Biochemica announces the appointment Dr. Michele Pedrocchi, former Global Head of Strategy and Business Development for Diagnostics at Roche, to its Board of Directors. Dr. Pedrocchi brings 25 years of international experience in in-vitro diagnostics, digital health, life sciences and personalized medicine.

Medix Biochemica has acquired USA-based Bioresource Technology Inc., a leading provider of base matrices for the in vitro diagnostics manufacturing industry worldwide

Medix Biochemica is launching a rejuvenated brand to reflect both the exciting improvements to its offering as a result of recent acquisitions, and its ongoing commitment to the in vitro diagnostics (IVD) industry.

Medix Biochemica has acquired 100 percent of the shares of myPOLS Biotec GmbH, a German manufacturer of innovative and high-quality raw materials in molecular diagnostics.

This year marks the fifth anniversary of Medix Biochemica in China. Over the past five years, Medix Biochemica China, and China’s IVD industry have undergone significant changes and developments.

Medix Biochemica presented the findings of a study ‘Monoclonal Serum Amyloid A antibodies applicable to human and veterinary diagnostic immunoassays with wide detection ranges’ in 2021 AACC exhibition in Atlanta, on September 28th.